Abstract:Objectives: To assess the health-related quality of life (QOL) in patients with acute coronary syndrome (ACS) and predict those patients who may have worsened QOL 6 months later and also observe the prescribing patterns of drugs given in their treatment. Materials and Methods: A prospective observational study was conducted at the cardiology department in a tertiary care hospital. The data were collected in both inpatient and outpatient cardiology departments based on our inclusion and exclusion criteria for a period of 6 months. A total of 240 patients were analyzed with a data collection form by interviewing the patients about their sociodemographic details, laboratory parameters, and diagnostic reports. The MacNew Heart Disease Questionnaire, Medical Research Council Breathlessness Scale, and New York Heart Association (NYHA) Functional Scale were used for assessing the QOL in patients with ACS. We calculated Global Registry of Acute Coronary Events Score and Thrombolysis in Myocardial Infarction Score for ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI) patients for identifying the mortality risk. Results: Urban people were more prone to ACS than rural people, according to our data. According to the NYHA Functional Classification, ability to do physical activity was more considerably affected in NSTEMI patients than STEMI and angina. Most of the patients had Grade 2 shortness of breath. 35% of the patients had a high mortality risk. Based on the MacNew Questionnaire data, 23% of the patients with ACS were doing emotionally poor, 45% of the patients had shown physically impaired symptoms, 28% of the patients were socially dependent, 8% of the patients showed poor gastric condition. 49% of the patients were given reperfusion therapy with either percutaneous coronary intervention (PCI) or coronary artery bypass graft, 25% of the patients were managed with dual-anticoagulant therapy, and 6% of the patients were treated with single-anticoagulant therapy. Commonly prescribed drug classes were statins (90%), antiplatelets (86%), anticoagulants (75%), antianginal (55%), beta-blockers (50%), diuretics (35%), angiotensin-converting enzyme inhibitors (18%), and angiotensin receptor blockers (16%). Conclusion: QOL was significantly affected in ACS patients. Most of the patients had risk factors for ACS. Patients explained impairments in all the four domains used in the questionnaire such as emotional, physical, social, and gastric impairments. QOL was more affected in STEMI patients and they had a high mortality risk. Most of the patients had NSTEMI. Low-risk patients were given single-anticoagulant therapy and medium-risk patients were treated with dual-anticoagulant therapy. PCI was preferred in almost all the patients.

Assessment of Quality Indicators for Acute Myocardial Infarction Management in 28 Countries and Use of Composite Quality Indicators for Benchmarking.

Clinical Analysis of 373 Patients with Non-ST Elevation Acute Coronary Syndrome in a Teaching Hospital

[Study on the Efficiency of the European System for Cardiac Operative Risk Evaluation (euroscore) in Predicting In-Hospital Mortality of the Patients with Percutaneous Coronary Intervention].

Global Geographical Variations in ST-segment Elevation Myocardial Infarction Management and Post-Discharge Mortality

Hospital-Based Quality Improvement Interventions for Patients With Acute Coronary Syndrome: A Systematic Review

Assessing Performance and Quality After Non-ST Segment Elevation Acute Coronary Syndromes

Regional Variations in Hospital Management and Post-Discharge Mortality in Patients with Non-St-segment Elevation Acute Coronary Syndrome

[A database in the coronary care unit to assess quality of care of acute myocardial infarction]

Clinical governance programme in patients with acute coronary syndrome: design and methodology of a quality improvement initiative

Clinical and organisational quality indicators for the optimal management of acute ischaemic stroke in the era of thrombectomy: a scoping review and expert consensus study

Health Care Quality Improvement for ST-Segment Elevation Myocardial Infarction: A Retrospective Study Based on Propensity-Score Matching Analysis

A survey and analysis of peri-operative quality indicators promoted by National Societies of Anaesthesiologists in Europe: The EQUIP project

The effect of a national quality improvement collaborative on prehospital care for acute myocardial infarction and stroke in England

Development of delivery indicators and delivery enablers for cardiovascular disease in the UK: a modified Delphi study

Identifying and Solving Gaps in Pre- and In-Hospital Acute Myocardial Infarction Care in Asia-Pacific Countries

Assessment of quality of life and drug prescription pattern in acute coronary syndrome

Performance on Management Strategies with Class I Recommendation and A Level of Evidence among Hospitalized Patients with Non-St-segment Elevation Acute Coronary Syndrome in China: Findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome (CCC-ACS) Project

Construction of Nursing-Sensitive Quality Indicators for Cardiac Catheterisation: A Delphi Study and an Analytic Hierarchy Process.

Use of cumulative mortality data in patients with acute myocardial infarction for early detection of variation in clinical practice: observational study

Association of inflammatory indicators with intensive care unit mortality in critically ill patients with coronary heart disease

Auditing Management of Acute Pancreatitis Using Comprehensive Quality Indicators